Table 1.
Means (and Standard Deviations) of study variables
| Measure | Pre-Treatment | Mid-Treatment | Post-Treatment | 3-Mo. Follow-up | 9-Mo. Follow-up |
|---|---|---|---|---|---|
| Diagnostic Outcomes | |||||
| GAD CSR | 5.75 (0.78) | 4.25 (1.24) | 2.71 (0.91) | 2.50 (1.05) | 2.25 (1.16) |
| MDD CSR* | 1.69 (2.27) | -- | 0.69 (1.45) | 0.25 (2.19) | 0.41 (0.93) |
| # Anxiety Diagnoses* | 0.81 (1.03) | -- | 0.14 (0.35) | 0.19 (0.40) | 0.10 (0.30) |
| # Mood Diagnoses* | 0.50 (0.51) | -- | 0.05 (0.22) | 0.00 (0.00) | 0.00 (0.00) |
| Self-Reported Anxiety Outcomes | |||||
| CGI Severity | 5.05 (0.52) | 4.00 (0.75) | 2.85 (0.67) | 2.32 (1.03) | 2.37 (1.17) |
| PSWQ | 66.63 (9.24) | 59.26 (8.20) | 52.35 (11.33) | 50.72 (12.21) | 47.31 (12.64) |
| STAI-7 | 19.59 (3.99) | 14.12 (2.37) | 12.78 (3.08) | 13.19 (4.94) | 13.14 (2.71) |
| MASQ-AA | 28.47 (6.72) | 23.89 (5.93) | 22.90 (5.44) | 22.67 (5.31) | 22.88 (3.24) |
| MASQ-GDA | 29.95 (5.87) | 24.52 (5.00) | 20.15 (4.64) | 20.67 (5.58) | 20.88 (6.05) |
| Self-Reported Depression Outcomes | |||||
| BDI-II | 16.90 (9.97) | 9.00 (8.60) | 6.20 (6.79) | 6.63 (6.91) | 5.23 (6.60) |
| MASQ-AD | 68.89 (14.29) | 64.05 (13.31) | 58.45 (14.38) | 59.28 (14.74) | 55.69 (13.47) |
| MASQ-GDD | 32.79 (9.90) | 27.95 (8.33) | 23.55 (7.86) | 24.61 (10.85) | 22.56 (8.24) |
| Disability/Quality of Life Outcomes | |||||
| Sheehan Disability Scale | 12.41 (6.65) | 9.53 (6.01) | 6.84 (4.93) | 7.12 (6.55) | 5.67 (5.22) |
| QOLI | 0.25 (1.48) | 0.71 (1.55) | 1.59 (1.42) | 1.40 (1.51) | 1.89 (1.58) |
| Model Related Outcomes | |||||
| DERS Total | 91.79 (20.67) | 85.21 (14.85) | 77.35 (19.85) | 75.94 (23.30) | 73.56 (16.21) |
| FFMQ Total | 115.29 (24.59) | 119.94 (14.17) | 130.47 (24.20) | 121.76 (15.53) | 130.75 (15.97) |
| EQ-Decentering | 30.53 (4.71) | 32.41 (4.09) | 36.11 (4.72) | 35.20 (4.52) | 36.93 (4.80) |
| ERQ-Reappraisal | 21.68 (5.81) | 26.44 (6.65) | 28.00 (4.21) | 27.94 (3.45) | 27.69 (5.57) |
| AIM-Negative Intensity | 38.67 (6.44) | 39.11 (5.86) | 35.11 (6.61) | 37.12 (5.73) | 34.75 (5.79) |
Note. GAD=generalized anxiety disorder, CSR=Clinician’s Severity Rating from the Anxiety Disorders Interview Schedule for DSM-IV, Lifetime Version; CGI=Clinical Global Impression; PSWQ=Penn State Worry Questionnaire; STAI=State Trait Anxiety Inventory; MASQ=Mood and Anxiety Symptom Questionnaire; AA=Anxious Arousal; GDA=General Distress Anxiousness; MDD=Major Depressive Disorder; BDI-II=Beck Depression Inventory-II; QOLI=Quality of Life Inventory; AD=Anhedonic Depression; GDD=General Distress Depression; QOLI=Quality of Life Inventory; DERS=Difficulties in Emotion Regulation Scale; FFMQ=Five Facet Mindfulness Questionnaire; ERQ=Emotion Regulation Questionnaire; EQ=Experiences Questionnaire; AIM=Affective Intensity Scale;
Clinician assessment not conducted at Mid-Treatment; Patients without MDD coded CSR=0